Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8623 |
High Similarity |
NPD1613 |
Approved |
0.8623 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.854 |
High Similarity |
NPD3027 |
Phase 3 |
0.8333 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8201 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8085 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7972 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7972 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.795 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7905 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7834 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7834 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7826 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.782 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.777 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD5588 |
Approved |
0.775 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7671 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7669 |
Intermediate Similarity |
NPD228 |
Approved |
0.7667 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD37 |
Approved |
0.7643 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7613 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7582 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7571 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7568 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7568 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7568 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7554 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7546 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7519 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7519 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7517 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7515 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7481 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7471 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7465 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7444 |
Intermediate Similarity |
NPD2684 |
Approved |
0.744 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7431 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7427 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7425 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7417 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7394 |
Intermediate Similarity |
NPD27 |
Approved |
0.7386 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7381 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7375 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7365 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7357 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7353 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7353 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7343 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7343 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7321 |
Intermediate Similarity |
NPD7472 |
Approved |
0.732 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.732 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7317 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7285 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7283 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7279 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7279 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7248 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7241 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.723 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7209 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7208 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD3060 |
Approved |
0.72 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7194 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7193 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD5763 |
Approved |
0.719 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7188 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7164 |
Intermediate Similarity |
NPD968 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD5773 |
Approved |
0.716 |
Intermediate Similarity |
NPD2978 |
Approved |
0.716 |
Intermediate Similarity |
NPD2977 |
Approved |
0.716 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7153 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7117 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7115 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7111 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD290 |
Approved |
0.7107 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7093 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7093 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7086 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7083 |
Intermediate Similarity |
NPD3092 |
Approved |
0.707 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7044 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7044 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7044 |
Intermediate Similarity |
NPD52 |
Approved |
0.7044 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7011 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6992 |
Remote Similarity |
NPD291 |
Approved |
0.6981 |
Remote Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD5535 |
Approved |
0.6975 |
Remote Similarity |
NPD4675 |
Approved |
0.6975 |
Remote Similarity |
NPD4678 |
Approved |
0.6974 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6974 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6972 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6964 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6964
|
Remote Similarity |
NPD3787 |
Discontinued |